Strong Revenue Growth
Consolidated revenues for Q4 2024 were $601 million, representing 9% growth on a constant currency basis. Healthcare revenues grew 9% to $368 million, and non-healthcare revenues grew 11% to $232 million.
Improved Gross and Operating Margins
For Q4 2024, consolidated gross margin was 52%, with healthcare gross margins improving by 190 basis points year-over-year. Operating profit was $134 million, representing 46% growth versus the prior year, with an operating margin of 22.4%, improving 570 basis points year-over-year.
Record New Contracts
Incremental value of new contracts was $432 million, indicating strong future revenue potential.
Positive Financial Guidance for 2025
Projected healthcare revenue for 2025 is $1.5 billion to $1.53 billion, representing 8% to 10% reported growth. Non-GAAP EPS guidance is $5.10 to $5.40, representing 22% to 29% growth.
Strong Operating Cash Flow
Generated $50 million in operating cash flow for Q4 2024 and $196 million for the full fiscal year 2024.
Successful Strategic Realignment
The company has refocused on its core healthcare business, improving cost structure and increasing operational efficiency.